Navigating discordant non-invasive fibrosis assessments in metabolic dysfunction-associated steatotic liver disease: Implications for generalizability, clinical decision-making, and resource allocation: Letter to the editor on “Histological severity and hepatic outcomes in patients with metabolic dysfunction-associated steatotic liver disease and discrepant FIB-4 and liver stiffness measurement”
Abstract
Navigating discordant non-invasive fibrosis assessments in metabolic dysfunction-associated steatotic liver disease: Implications for generalizability, clinical decision-making, and resource allocation: Letter to the editor on "Histological severity and hepatic outcomes in patients with metabolic dysfunction-associated steatotic liver disease and discrepant FIB-4 and liver stiffness measurement"
Fields of Study & Subjects
Cystic Fibrosis Research Advances
Parathyroid Disorders and Treatments
Nutrition and Health in Aging
Publication details
- Journal / source
- Clinical and Molecular Hepatology
- Publisher
- The Korean Association for the Study of the Liver
- Volume
- 32
- Issue
- 3
- Pages
- e300–e302
- Publication date
- 20 February 2026
- Language
- EN